AXA SA vs Canon Inc.: Strategic Comparison

This in-depth comparison examines AXA SA and Canon Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching AXA SA on its own, evaluating Canon Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between AXA SA and Canon Inc. is widest.

On the headline numbers, AXA SA reports annual revenue of ~$131.1B against ~$31B for Canon Inc., while their respective market capitalizations stand at $90.3B and $25.6B. AXA SA is headquartered in France and Canon Inc. in Japan, and those different home markets shape how each company competes.

AXA SA: AXA SA is a Paris-based insurance group and one of the largest insurers in the world by revenue. It says it employs 156,000 people serving more than 92 million clients in 52 countries, and reported gross written premiums and other revenues of ~$131 billion (EUR 116 billion) for 2025. The group writes motor, home, commercial property, liability and specialty cover, life and savings contracts and health insurance, and manages the reserves backing those policies. Property and casualty is the largest business at ~$65.5 billion (EUR 58 billion) of 2025 premiums, ahead of life at ~$42.4 billion (EUR 37.5 billion) and health at ~$21.5 billion (EUR 19 billion).

Canon Inc.: Canon is a diversified Japanese manufacturer organized into four business units. Printing (office multifunction devices, laser and inkjet printers, production presses) is the largest. Imaging includes EOS cameras, RF lenses, cinema cameras and Axis network cameras. Medical, built on the 2016 purchase of Toshiba Medical Systems, makes CT, MRI, ultrasound and X-ray equipment. Industrial supplies semiconductor and flat-panel lithography tools and Canon Tokki OLED deposition systems. The group had 321 consolidated subsidiaries and 165,547 employees at the end of 2025, and its shares trade on the Tokyo Stock Exchange under code 7751.

AXA SA and Canon Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between AXA SA and Canon Inc..

AXA SA business model: AXA collects premiums across three businesses: property and casualty (motor, home, commercial property, liability and specialty risks written through AXA XL), life and savings (protection, general account savings and unit-linked contracts), and health (individual cover and employee benefits). In 2025 property and casualty premiums reached ~$65.5 billion (EUR 58 billion) and life and health premiums ~$63.8 billion (EUR 56.5 billion). Policies are sold through tied agents, brokers, bancassurance partners and direct digital channels. The group also earns investment income on the reserves it holds before claims are paid. Since selling AXA Investment Managers to BNP Paribas Cardif on July 1, 2025, AXA no longer runs a third-party asset manager and has BNP Paribas manage a large part of its own assets under a long-term agreement.

Canon Inc. business model: Canon designs, builds and sells hardware, then earns recurring revenue from consumables, service contracts and software on the installed base. In 2025 the Printing Business Unit produced ~$16.7 billion (¥2,494.4 billion) of sales (54%), split between office multifunction devices (~$7.13 billion (¥1,063.7 billion)), prosumer laser and inkjet printers (~$6.66 billion (¥993.4 billion)) and production presses (~$2.93 billion (¥437.3 billion)); toner, ink and maintenance on machines already in the field account for much of that income. Imaging (~$7.07 billion (¥1,054.9 billion), 23%) covers EOS cameras and lenses (~$4.19 billion (¥625.5 billion)) plus network cameras and video software from Axis and Milestone (~$2.88 billion (¥429.4 billion)). Medical (~$3.89 billion (¥580.6 billion), 13%) sells CT, MRI, ultrasound and X-ray systems and service. Industrial (~$2.42 billion (¥361.1 billion), 8%) sells semiconductor and flat-panel lithography tools, Canon Tokki OLED deposition systems and sputtering equipment. Canon sells through regional companies such as Canon U.S.A., Canon Europe and Canon Marketing Japan, and spent ~$2.27 billion (¥339.3 billion), about 7.3% of sales, on R&D in 2025.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of AXA SA stack up against those of Canon Inc..

AXA SA competitive advantage: AXA's main advantage is a diversified risk pool. Writing motor, home, commercial property, liability, health and life cover in 52 countries lets one bad year in a single market or line be absorbed elsewhere: in 2025 growth in health and European commercial lines offset pressure in other portfolios. Its balance sheet supports that spread, with a Solvency II ratio of 224% at the end of 2025. The 2018 purchase of XL Group added Lloyd's market access and large-corporate broker relationships that regional insurers cannot match, and the AXA brand supports distribution through tied agents, brokers and bancassurance partners across Europe and Asia.

Canon Inc. competitive advantage: Canon's edge is vertical integration in optics and imaging. It designs its own lenses, CMOS image sensors, print engines and image-processing chips, and builds much of its own production equipment. That depth shows in its patent output (seventh in U.S. patent grants in 2025 and in the top 10 for 42 straight years, according to IFI Claims) and in a camera business that has held the No. 1 interchangeable-lens share for 23 consecutive years. In printing, a large installed base of office devices produces recurring toner and service revenue that new entrants cannot easily copy.

Future prospects matter as much as current results. The growth strategies below explain how AXA SA and Canon Inc. each plan to expand from here.

AXA SA growth strategy: AXA grows mostly organically in insurance lines it can price, supplemented by bolt-on deals: Laya Healthcare in Ireland and GACM España in 2023, and a 51% stake in the Italian direct insurer Prima announced in 2025 for ~$565 million (EUR 500 million). The bigger strategic move has been simplification. AXA listed and sold down its United States life business as Equitable Holdings from 2018, bought XL Group to build commercial lines, and completed the sale of AXA Investment Managers to BNP Paribas Cardif on July 1, 2025, using part of the proceeds for a ~$4.29 billion (EUR 3.8 billion) buyback. Management also reports efficiency gains from automation and artificial intelligence in claims and service work.

Canon Inc. growth strategy: Phase VII sets 2030 sales targets for each unit: Printing ~$18.8 billion (¥2.8 trillion) (about 2% a year), Imaging ~$8.98 billion (¥1.34 trillion) (5%), Medical ~$5.03 billion (¥750 billion) (5%) and Industrial ~$4.02 billion (¥600 billion) (10%). Growth products named in the plan are nanoimprint lithography, photon-counting CT and industrial printing equipment. Canon merged Canon Medical Systems' operations into Canon Inc. on April 1, 2026, is taking Canon Electronics private to build a space business worth ~$134 million (¥20 billion) or more in sales by 2030, and wants emerging markets such as India, Indonesia, Africa, the Middle East and Latin America to rise from 10% to 15% of sales. In Printing it plans to cut production staff by 30% and factory space by 40% by 2028 and to outsource hardware that needs no special technology.

A closer look at the financial trajectory of AXA SA and Canon Inc. rounds out the comparison.

AXA SA: AXA's results combine large, slow-moving premium income with investment income on the reserves it holds. In 2025 gross written premiums and other revenues rose 6% to ~$131 billion (EUR 116 billion), underlying earnings rose 6% to ~$9.49 billion (EUR 8.4 billion), underlying earnings per share rose 8% to EUR 3.86 and net income rose to ~$11.1 billion (EUR 9.80 billion), helped by the gain on the sale of AXA Investment Managers. The property and casualty combined ratio improved 0.3 points to 90.6%, so underwriting itself was profitable before investment income. The Solvency II ratio ended 2025 at 224%, and 215% on January 1, 2026 once capital instruments under Solvency II transitional measures stopped qualifying. AXA proposed a dividend of EUR 2.32 per share for 2025, up 8%, alongside an annual buyback of up to $1.41 billion (EUR 1.25 billion).

Canon Inc.: Canon's sales fell from ~$27.3 billion (¥4,080.0 billion) in 2017, the first full year with Toshiba Medical, to ~$21.2 billion (¥3,160.2 billion) in 2020 as cameras and office printing shrank and the pandemic hit. They have grown every year since, reaching a record ~$31 billion (¥4,624.7 billion) in 2025 (+2.5%). Operating profit was ~$3.05 billion (¥455.4 billion) in 2025, a 9.8% margin, up from ~$1.87 billion (¥279.8 billion) in 2024, when a ~$1.11 billion (¥165.1 billion) goodwill impairment on the medical business cut net income to ~$1.07 billion (¥160.0 billion). Net income attributable to Canon Inc. more than doubled to ~$2.23 billion (¥332.1 billion) and EPS rose to ¥367.48. Canon paid a ¥160 dividend (42.9% payout), generated ~$1.6 billion (¥238.5 billion) of free cash flow and ended 2025 with ~$6.34 billion (¥946.2 billion) of interest-bearing debt, up from ~$4.45 billion (¥663.5 billion). By region, the Americas supplied 32% of 2025 sales, Europe 26%, Japan 21% and Asia and Oceania 21%. In July 2026, after record second-quarter sales, Canon guided to ~$32.2 billion (¥4,800.0 billion) of 2026 sales and ~$3.12 billion (¥465.0 billion) of operating profit.